)
One of Australia's most promising founder-led tech scale-ups Harrison.ai has gained the expertise of leading business executive Robyn Denholm on its board, following her appointment on 1 July.
Hailing from South West Sydney and with senior executive experience at California-based companies Sun Microsystems and Juniper Networks, as well as Telstra (ASX: TLS) more recently, Denholm currently serves as operating partner of Blackbird Ventures and chairs the board at global electric vehicle giant Tesla.
Harrison.ai is a clinician-led healthcare AI company that develops and deploys AI diagnostic-assist solutions to increase accuracy and efficiency.
Founded in 2018 by Dr Aengus Tran, a medical doctor, and his brother Dimitry Tran, Harrison.ai uses AI to design new algorithms and treatments for healthcare professionals to help increase accuracy and efficiency.
The company has pioneered a unique model to commercialise AI medical solutions, which automate key tasks using AI, with the aim to elevate the care clinicians can provide.
Harrison.ai expects Denholm's extensive experience as a strategic advisor overseeing governance and commercialisation at leading international brands will be invaluable to the company as it looks towards its next phase of growth.
"I'm incredibly excited to be joining the Harrison.ai Board, having been a strategic advisor to the organisation for some time now," Denholm says.
"I look forward to working with the Board to realise the Harrison.ai mission to scale global healthcare capacity using AI."
Harrison.ai co-founder and CEO Dr Aengus Tran says the group is thrilled to announce Denholm has joined the board.
"Robyn believes in our vision and brings a wealth of knowledge that will be invaluable as we look to our next phase of growth," says Tran, who alongside his brother featured in the 2023 Australia's Top 100 Young Entrepreneurs list.
The company's first joint venture with I-MED Radiology Network, Annalise.ai, has already commercialised two flagship products, Annalise Enterprise CTB and Annalise Enterprise CXR. These are among the most complete and comprehensive AI decision-support solutions available for non-contrast CT brain studies and chest X-rays, respectively.
In late 2021 Harrison.ai established a second joint venture with Sonic Healthcare, Franklin.ai, to focus on bringing AI to the world of pathology.
"Globally, the healthcare industry faces immense pressure and capacity shortages in clinical diagnosis and treatment," says Dr Tran.
"AI automation can play a vital role in addressing systemic issues and improving access to care, and we believe Harrison.ai has the opportunity to impact the sector significantly."
Get our daily business news
Sign up to our free email news updates.
)
)
)
)
)
